X-46837114-TCTC-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PM4_SupportingPP5_Moderate
The ENST00000218340.4(RP2):c.16_18del(p.Ser6del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Genomes: not found (cov: 23)
Consequence
RP2
ENST00000218340.4 inframe_deletion
ENST00000218340.4 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.27
Genes affected
RP2 (HGNC:10274): (RP2 activator of ARL3 GTPase) The RP2 locus has been implicated as one cause of X-linked retinitis pigmentosa. The predicted gene product shows homology with human cofactor C, a protein involved in the ultimate step of beta-tubulin folding. Progressive retinal degeneration may therefore be due to the accumulation of incorrectly-folded photoreceptor or neuron-specific tubulin isoforms followed by progressive cell death [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in ENST00000218340.4. Strenght limited to Supporting due to length of the change: 1aa.
PP5
Variant X-46837114-TCTC-T is Pathogenic according to our data. Variant chrX-46837114-TCTC-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 10544.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chrX-46837114-TCTC-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RP2 | NM_006915.3 | c.16_18del | p.Ser6del | inframe_deletion | 1/5 | ENST00000218340.4 | NP_008846.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RP2 | ENST00000218340.4 | c.16_18del | p.Ser6del | inframe_deletion | 1/5 | 1 | NM_006915.3 | ENSP00000218340 | P1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 genomes
Cov.:
23
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 23
GnomAD4 genome
Cov.:
23
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 26, 2022 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies have shown that this variant affects RP2 function (PMID: 10942419, 28209709). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 10544). This variant is also known as del Ser6, S6del, ∆Ser6, ∆S6. This variant has been observed in individuals with X-linked retinitis pigmentosa (PMID: 9697692, 10520237, 17724181, 30718709; Invitae). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs137852284, gnomAD 0.01%), including at least one homozygous and/or hemizygous individual. This variant, c.16_18del, results in the deletion of 1 amino acid(s) of the RP2 protein (p.Ser6del), but otherwise preserves the integrity of the reading frame. - |
Retinitis pigmentosa 2 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 12, 2000 | - - |
Retinitis pigmentosa Pathogenic:1
Pathogenic, no assertion criteria provided | research | Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet | Apr 01, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at